ClinicalTrials.Veeva

Menu
O

Oaxaca Site Management Organization S.C. | Oaxaca, Mexico

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Avelumab
Pembrolizumab
Sunitinib
Olaparib
PF-05280014
Obeldesivir
Ibrutinib
MK-0616
Paclitaxel
MK-7339

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

6 of 14 total trials

(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors

This is a Phase 3, open-label, international, multicenter study of CGT9486 in combination with sunitinib. This is a multi-part study that will enroll...

Enrolling
Metastatic Cancer
Advanced Gastrointestinal Stromal Tumors
Drug: CGT9486
Drug: Sunitinib

The purpose of this study is to collect long-term safety and efficacy data for participants treated with ibrutinib and to provide ongoing access to i...

Invitation-only
Waldenstrom Macroglobulinemia
Follicular Lymphoma
Drug: Ibrutinib

This Master Protocol for Avelumab Continuation Sub-Studies is to provide continued treatment access, safety follow-up, and when applicable, overall s...

Active, not recruiting
Advanced Malignancies
Urothelial Cancer
Drug: Lorlatanib
Drug: CMP 001

This study will evaluate the efficacy and safety of olaparib (MK-7339) monotherapy in participants with multiple types of advanced cancer (unresectab...

Enrolling
Advanced Solid Neoplasms
Drug: Olaparib

This is a phase 3, randomized, placebo-controlled study of the efficacy and safety of MK-0616, an oral proprotein convertase subtilisin/kexin type 9...

Enrolling
Arteriosclerosis
Hypercholesterolaemia
Drug: Placebo
Drug: MK-0616

This is a phase 3 study to evaluate zimberelimab (AB122) combined with domvanalimab (AB154) compared to pembrolizumab in front-line, PD-L1-high, loca...

Active, not recruiting
Squamous Non Small Cell Lung Cancer
Nonsquamous Non Small Cell Lung Cancer
Drug: Pembrolizumab
Drug: Pemetrexed

Trial sponsors

Pfizer logo
Merck Sharp & Dohme (MSD) logo
Arcus Biosciences logo
C
Gilead Sciences logo
Incyte logo
Janssen (J&J Innovative Medicine) logo
L
Merck KGaA (EMD Serono) logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems